How to design and launch a successful Clinical Trial Manufacturing.

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

rAAVs are widely used viral vectors in human gene therapy ... Form of DNA Impurities into the Capsid of a Recombinant Adeno-Associated Virus, Human Gene Therapy (2025). DOI: 10.1089/hum.

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

The death of a 16-year-old boy taking a gene therapy this month dealt a fresh blow to the Duchenne muscular dystrophy ...

The USP, NIST, and five leading biotech companies participated in a study to compare commonly used techniques to determine ...

AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company, in collaboration with the Telethon Institute of Genetics and Medicine (TIGEM), announces the publication of their preclinical ...

Inherited retinal degeneration (IRD) encompasses various disorders characterized by progressive loss of retinal photoreceptor cells, ultimately leading to vision loss and blindness.